UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter) |
|
| |||
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
(Address of principal executive offices, including zip code)
(
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
—————----
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2):
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On March 29, 2024, Catheter Precision, Inc. (the “Company”) filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”) with the Securities and Exchange Commission (the “SEC”). The Consent of Independent Registered Public Accounting Firm dated March 29, 2024 and filed as Exhibit 23.1 to the Form 10-K made reference to Registration Statement on Form S-3 333-269491, and to Registration Statement on Form S-3 Amendment No.1 No. 333-270919, instead of making reference to Registration Statements on Post-Effective Amendment No. 1 to Form S-3 on Form S-1 333-269491 and 333-270919. A new Consent of Independent Registered Public Accounting Firm, dated April 2, 2024 (the “Revised Consent”), has revised the references to such registration statements accordingly, is attached as Exhibit 23.1 to this Current Report on Form 8-K, and is hereby filed with the SEC. The Revised Consent does not change any previously reported financial results or other disclosure contained in the Form 10-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
| Description |
| Consent of WithumSmith+Brown, PC, Independent Registered Public Accounting Firm. | |
104 |
| The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CATHETER PRECISION, INC. | |||
| Date: April 2, 2024 | By: | /s/ Margrit Thomassen | |
|
| Margrit Thomassen Interim Chief Financial Officer | |
3 |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 No. 333-262195, 333-240187, and 333-227552, on Form S-1 Amendment No. 1 No. 333-239887, on Form S-1 Amendment No. 2 No. 333-237701, on Form S-3 No. 333-267443 and 333-271388, on Post-Effective Amendment No. 1 to Form S-3 on Form S-1 No. 333-270919 and 333-269491, on Form S-8 No. 333-264495, 333-254370, 333-250094, 333-237096, 333-230332, 333-227696, 333-269612 and 333-273351 of Catheter Precision, Inc. (the Company) of our report dated March 29, 2024, (which includes an explanatory paragraph relating to Catheter Precision, Inc.’s ability to continue as a going concern) relating to the consolidated financial statements of Catheter Precision, Inc. as of and for the year ended December 31, 2023, which appeared in the Company’s Form 10-K filed March 29, 2024.
/s/ WithumSmith+Brown, PC
East Brunswick, New Jersey
April 2, 2024
Cover |
Apr. 02, 2024 |
|---|---|
| Cover [Abstract] | |
| Entity Registrant Name | Catheter Precision, Inc. |
| Entity Central Index Key | 0001716621 |
| Document Type | 8-K |
| Amendment Flag | false |
| Entity Emerging Growth Company | false |
| Document Period End Date | Apr. 02, 2024 |
| Entity File Number | 001-38677 |
| Entity Incorporation State Country Code | DE |
| Entity Tax Identification Number | 38-3661826 |
| Entity Address Address Line 1 | 1670 Highway 160 West |
| Entity Address Address Line 2 | Suite 205 |
| Entity Address City Or Town | Fort Mill |
| Entity Address State Or Province | SC |
| Entity Address Postal Zip Code | 29708 |
| City Area Code | 973 |
| Local Phone Number | 691-2000 |
| Security 12b Title | Common Stock, par value $0.0001 per share |
| Trading Symbol | VTAK |
| Security Exchange Name | NYSEAMER |
| Written Communications | false |
| Soliciting Material | false |
| Pre Commencement Tender Offer | false |
| Pre Commencement Issuer Tender Offer | false |